Related references
Note: Only part of the references are listed.Adipocyte and Adipokines Promote a Uterine Leiomyoma Friendly Microenvironment
Sadia Afrin et al.
NUTRIENTS (2023)
Correlation between inflammatory marker and lipid metabolism in patients with uterine leiomyomas
Yanan Duan et al.
FRONTIERS IN MEDICINE (2023)
Adipocyte coculture induces a pro-inflammatory, fibrotic, angiogenic, and proliferative microenvironment in uterine leiomyoma cells
Sadia Afrin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2023)
Uterine Transcriptome: Understanding Physiology and Disease Processes
Gregory W. Kirschen et al.
BIOLOGY-BASEL (2023)
Beta blockers reduce uterine fibroid incidence in hypertensive women
Nicole M. Fischer et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2023)
PEGylated Polymeric Nanoparticles Loaded with 2-Methoxyestradiol for the Treatment of Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model
Sanaalarab Al Enazy et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2023)
Cardiometabolic profile of women with uterine leiomyoma: a cross-sectional study
Abdelrahman Alashqar et al.
MINERVA OBSTETRICS AND GYNECOLOGY (2023)
The miR-23-27-24 clusters drive lipid-associated macrophage proliferation in obese adipose tissue
Neil T. Sprenkle et al.
CELL REPORTS (2023)
Simvastatin inhibits stem cell proliferation in human leiomyoma via TGF-beta 3 and Wnt/beta-Catenin pathways
Sadia Afrin et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2022)
Hypoxia induces proliferation via NOX4-Mediated oxidative stress and TGF-β3 signaling in uterine leiomyoma cells
Mariko Miyashita-Ishiwata et al.
FREE RADICAL RESEARCH (2022)
Myometrial oxidative stress drives MED12 mutations in leiomyoma
Yinuo Li et al.
CELL AND BIOSCIENCE (2022)
A Possible Cause for the Differential Expression of a Subset of miRNAs in Mesenchymal Stem Cells Derived from Myometrium and Leiomyoma
Mariangela Di Vincenzo et al.
GENES (2022)
The Potential of Transforming Growth Factor-beta Inhibitor and Vascular Endothelial Growth Factor Inhibitor as Therapeutic Agents for Uterine Leiomyoma
Jung Yoon Park et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2022)
Angiotensin-Converting Enzyme Inhibitors Reduce Uterine Fibroid Incidence in Hypertensive Women
Nicole M. Fischer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies
Abdelrahman AlAshqar et al.
BIOLOGY OF REPRODUCTION (2021)
The complex role of adipokines in obesity, inflammation, and autoimmunity
Erin B. Taylor
CLINICAL SCIENCE (2021)
New Insights on the Relationship between Leptin, Ghrelin, and Leptin/Ghrelin Ratio Enforced by Body Mass Index in Obesity and Diabetes
Adela-Viviana Sitar-Taut et al.
BIOMEDICINES (2021)
Leptin and Obesity: Role and Clinical Implication
Milan Obradovic et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Vascular biology of uterine fibroids: connecting fibroids and vascular disorders
Gregory W. Kirschen et al.
REPRODUCTION (2021)
Diet and Nutrition in Gynecological Disorders: A Focus on Clinical Studies
Sadia Afrin et al.
NUTRIENTS (2021)
Relationship between early follicular serum estrone level and other hormonal or ultrasonographic parameters in women with polycystic ovary syndrome
Sungwook Chun
GYNECOLOGICAL ENDOCRINOLOGY (2020)
CXCL12 Attracts Bone Marrow-Derived Cells to Uterine Leiomyomas
Irene Moridi et al.
REPRODUCTIVE SCIENCES (2020)
Differential contribution of Nox1, Nox2 and Nox4 to kidney vascular oxidative stress and endothelial dysfunction in obesity
Mercedes Munoz et al.
REDOX BIOLOGY (2020)
Progesterone receptor membrane associated component 1 enhances obesity progression in mice by facilitating lipid accumulation in adipocytes
Ryogo Furuhata et al.
COMMUNICATIONS BIOLOGY (2020)
Lower prevalence of non-cavity-distorting uterine fibroids in patients with polycystic ovary syndrome than in those with unexplained infertility
Hao Huang et al.
FERTILITY AND STERILITY (2019)
Cardiometabolic Risk Factors and Benign Gynecologic Disorders
Abdelrahman AlAshqar et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2019)
Pathogenomics of Uterine Fibroids Development
Vladislav S. Baranov et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Role of Tumor Necrosis Factor in the Biology of Uterine Fibroids and the Related Symptoms
Michal Ciebiera et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications
Mostafa A. Borahay et al.
REPRODUCTIVE SCIENCES (2017)
Activin A in Inflammation, Tissue Repair, and Fibrosis: Possible Role as Inflammatory and Fibrotic Mediator of Uterine Fibroid Development and Growth
Olga Protic et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2017)
Leptin in inflammation and autoimmunity
Antonio La Cava
CYTOKINE (2017)
Combined Oral Contraceptive for Treatment of Women with Uterine Fibroids and Abnormal Uterine Bleeding: A Systematic Review
Rafael M. Moroni et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2015)
BMP4 depletion by miR-200 inhibits tumorigenesis and metastasis of lung adenocarcinoma cells
Jeong Seon Kim et al.
MOLECULAR CANCER (2015)
The effect of equine metabolic syndrome on the ovarian follicular environment
D. R. Sessions-Bresnahan et al.
JOURNAL OF ANIMAL SCIENCE (2014)
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity
B. Spoto et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2014)
miR-200c Regulates IL8 Expression by Targeting IKBKB: A Potential Mediator of Inflammation in Leiomyoma Pathogenesis
Tsai-Der Chuang et al.
PLOS ONE (2014)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women
Anne Zimmermann et al.
BMC WOMENS HEALTH (2012)
Functional relevance of the histone γH2Ax in the response to DNA damaging agents
Ingrid Revet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas
Netta Makinen et al.
SCIENCE (2011)
BMI and Uterine Size: Is There Any Relationship?
Vani Dandolu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2010)
Relationship between metabolic syndrome and uterine leiomyomas: A case-control study
Takashi Takeda et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2008)
Polycystic ovary syndrome and risk of uterine leiomyomata
Lauren A. Wise et al.
FERTILITY AND STERILITY (2007)
A key role of leptin in the control of regulatory T cell proliferation
Veronica De Rosa et al.
IMMUNITY (2007)
Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases
KD Martyn et al.
CELLULAR SIGNALLING (2006)
Influence of body size and body fat distribution on risk of uterine leiomyomata in US Black women
LA Wise et al.
EPIDEMIOLOGY (2005)
Adiponectin and adiponectin receptors
T Kadowaki et al.
ENDOCRINE REVIEWS (2005)
Adiponectin is associated with vascular function independent of insulin sensitivity
JM Fernández-Real et al.
DIABETES CARE (2004)
Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation
KCB Tan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets:: Possible role of oxidative stress
S Piro et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2002)
Elevated serum leptin concentrations induced by experimental acute inflammation
O Gualillo et al.
LIFE SCIENCES (2000)